Every signature helps demonstrate that Canadians want change for one of the deadliest—but most underfunded—cancers.
Every signature helps demonstrate that Canadians want change for one of the deadliest—but most underfunded—cancers.
• National standards in care
• Access to clinical trials & treatments like Onivyde
• Somatic testing for patients regardless of location
• National standards in care
• Access to clinical trials & treatments like Onivyde
• Somatic testing for patients regardless of location
Read the full story here: heathercutler.ca/the-heather-...
Read the full story here: heathercutler.ca/the-heather-...
Nazanin, Moshfeka, Sanaz, Shah, Ben, Raji, Fadi, Sayem, Farzaneh, and Fadeelatu.
Nazanin, Moshfeka, Sanaz, Shah, Ben, Raji, Fadi, Sayem, Farzaneh, and Fadeelatu.
📄 drive.proton.me/urls/8VQB0J57W…
We’re committed to full transparency on where we stand and how we’re working for change.
📄 drive.proton.me/urls/8VQB0J57W…
We’re committed to full transparency on where we stand and how we’re working for change.
This is about building sustained, open dialogue—starting right here at home.
This is about building sustained, open dialogue—starting right here at home.
We know smaller provinces can lead when they invest in smart, scalable policy. #PancreaticCancer #HealthEquity
We know smaller provinces can lead when they invest in smart, scalable policy. #PancreaticCancer #HealthEquity
We’ve outlined four key recommendations for NL:
•Launch high-risk pancreatic cancer screening
•Expand access to genetic testing
•Integrate precision medicine
•Fund Onivyde, a Health Canada–approved treatment still unavailable to most Canadians
We’ve outlined four key recommendations for NL:
•Launch high-risk pancreatic cancer screening
•Expand access to genetic testing
•Integrate precision medicine
•Fund Onivyde, a Health Canada–approved treatment still unavailable to most Canadians